Showing results (461-470 of 673) with videos related to
Sort By:
Pageof 68
The Journal of Biological Chemistry|May 19, 2005
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transitionDaniel Duran-Sandoval, Bertrand Cariou, Fredéric Percevault, et al.Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonistsYukiyoshi Yamazaki, Kazutoyo Abe, Tsutomu Toma, et al.Journal of Lipid Research|March 13, 2013
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formationFilippo Molica, Fabienne Burger, Aurélien Thomas, et al.International Journal of Molecular Sciences|November 13, 2021
Gene Doping with Peroxisome-Proliferator-Activated Receptor Beta/Delta Agonists Alters Immunity but Exercise Training Mitigates the Detection of Effects in Blood SamplesBrigitte Sibille, Isabelle Mothe-Satney, Gwenaëlle Le Menn, et al.Diabetes|May 30, 2006
Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human isletsFanny Lalloyer, Brigitte Vandewalle, Frédéric Percevault, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Apolipoprotein A5 controls fructose-induced metabolic dysregulation in miceClaudia Ress, Jochen Dobner, Kerstin Rufinatscha, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|September 30, 2006
Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterolSabine M Post, Martine Groenendijk, Caroline C van der Hoogt, et al.Diabetes|March 16, 2007
PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetesTakafumi Nakamachi, Takashi Nomiyama, Florence Gizard, et al.FEBS Letters|October 22, 2013
PPARalpha regulates the production of serum Vanin-1 by liverSamuel Rommelaere, Virginie Millet, Thomas Gensollen, et al.Journal of Hepatology|May 24, 2023
NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation studyStephen A Harrison, Vlad Ratziu, Jeremy Magnanensi, et al.Pageof 68